EOM Pharmaceuticals Holdings, Inc. (IMUC) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Montvale, NJ, United States. El CEO actual es Irach Taraporewala.
IMUC tiene fecha de IPO 2021-01-08, 3 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $14.69M.
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
